Difficulty: Medium
Average Score: 92%
Practice
A defect in a vaccine product should be reported:
Correct answer
C
Rationale
In infection prevention and control, it is crucial to ensure the safety and efficacy of vaccines to protect public health. Reporting defects in vaccine products is a critical aspect of maintaining this safety. The correct answer is option C: To a report center of the Medicines and Healthcare products Regulatory Agency (MHRA).
The MHRA is the regulatory body responsible for ensuring that medicines and medical devices work effectively and are safe for use. Reporting defects to the MHRA allows for prompt investigation and necessary actions to be taken to prevent harm to patients. This process is essential for monitoring the quality and safety of vaccines in circulation.
Option A, using the Yellow Card Scheme, is used for reporting adverse drug reactions, not defects in vaccine products. Option B, using the Black Triangle Scheme, is used for reporting adverse drug reactions for new medications. Option D, reporting only to the vaccine manufacturer, may not ensure that the regulatory agency is informed of potential issues.
Educationally, understanding the correct reporting mechanisms for vaccine defects is crucial for healthcare professionals to uphold patient safety and contribute to public health efforts. By being aware of the appropriate channels for reporting, healthcare providers can actively participate in maintaining the quality and effectiveness of vaccines, ultimately preventing the spread of infectious diseases.
The MHRA is the regulatory body responsible for ensuring that medicines and medical devices work effectively and are safe for use. Reporting defects to the MHRA allows for prompt investigation and necessary actions to be taken to prevent harm to patients. This process is essential for monitoring the quality and safety of vaccines in circulation.
Option A, using the Yellow Card Scheme, is used for reporting adverse drug reactions, not defects in vaccine products. Option B, using the Black Triangle Scheme, is used for reporting adverse drug reactions for new medications. Option D, reporting only to the vaccine manufacturer, may not ensure that the regulatory agency is informed of potential issues.
Educationally, understanding the correct reporting mechanisms for vaccine defects is crucial for healthcare professionals to uphold patient safety and contribute to public health efforts. By being aware of the appropriate channels for reporting, healthcare providers can actively participate in maintaining the quality and effectiveness of vaccines, ultimately preventing the spread of infectious diseases.